Markus Reich
Private Equity Investor bij Cross Equity Partners AG
Profiel
Mr. Markus Reich is Managin Partner at Cross Equity Partners AG.
He was Partner in the Growth Capital Partnership and co-head of 3i Switzerland, which he helped establish in early 2000.
Before joining 3i he was a member of the Executive Board of the largest Swiss management consulting company, focusing on interim management, turnarounds and reorganisations, and mergers and acquisitions.
Markus specialises in growth capital investments and buyouts in Switzerland.
Key deals that he has been involved in include ECS (producer of specific inks and dyes), u-blox (provider of positioning technology), Arpida (development of anti-infective drugs), MIB AG (facility management) and Pilatus Flugzeugwerke AG (aircraft manufacturer).Markus is a board member of a world market leading conglomerate in cosmetic products/direct sales and a lecturer at top management and finance courses on private equity.
He is also a founding member of a Rotary Club in Switzerland.He studied Business Administration at the University Zurich and holds a Master of Business Administration (lic.
oec.) with majors in management, corporate finance and accounting.
Actieve functies van Markus Reich
| Bedrijven | Functie | Begin |
|---|---|---|
Cross Equity Partners AG
 Cross Equity Partners AG Investment ManagersFinance Cross Equity Partners AG (Cross) is an independent private equity firm headquartered in Pfäffikon, Switzerland. The firm was founded in 2008. | Private Equity Investor | 03-06-2010 |
Eerdere bekende functies van Markus Reich
| Bedrijven | Functie | Einde |
|---|---|---|
3i Schweiz AG
 3i Schweiz AG Investment ManagersFinance 3i Schweiz AG (3i Schweiz) is the Swiss private equity subsidiary of 3i Group Plc (LSE: III) in Great Britain. 3i Schweiz AG is headquartered in Zurich. | Directeur/Bestuurslid | 01-01-2007 |
Micro-Macinazione SA
 Micro-Macinazione SA Pharmaceuticals: MajorHealth Technology Micro-Macinazione SA provides micronization technologies and services for the pharmaceutical and fine chemical industry. The firm offers services for the micronization of bulk active pharmaceutical ingredients and also designs and produces jet spiral jet mills, isolated jet mills, cosmetic jet mills, isolators, feeders, cryogenic exchangers and ancillary equipment which are used in the micronization process. The company was founded in 1970 and is headquartered in Molinazzo di Monteggio, Switzerland. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
3i Schweiz AG
3i Schweiz AG Investment ManagersFinance 3i Schweiz AG (3i Schweiz) is the Swiss private equity subsidiary of 3i Group Plc (LSE: III) in Great Britain. 3i Schweiz AG is headquartered in Zurich. | Finance |
Cross Equity Partners AG
Cross Equity Partners AG Investment ManagersFinance Cross Equity Partners AG (Cross) is an independent private equity firm headquartered in Pfäffikon, Switzerland. The firm was founded in 2008. | Finance |
Micro-Macinazione SA
Micro-Macinazione SA Pharmaceuticals: MajorHealth Technology Micro-Macinazione SA provides micronization technologies and services for the pharmaceutical and fine chemical industry. The firm offers services for the micronization of bulk active pharmaceutical ingredients and also designs and produces jet spiral jet mills, isolated jet mills, cosmetic jet mills, isolators, feeders, cryogenic exchangers and ancillary equipment which are used in the micronization process. The company was founded in 1970 and is headquartered in Molinazzo di Monteggio, Switzerland. | Health Technology |
